|
1
|
Zhang Y, Cai B, Jiang H, Yan H, Yang H,
Peng J, Wang W, Ma S, Wu X and Peng X: Use of 1H-nuclear magnetic
resonance to screen a set of biomarkers for monitoring metabolic
disturbances in severe burn patients. Crit Care. 18:R1592014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jeschke MG, Gauglitz GG, Kulp GA, Finnerty
CC, Williams FN, Kraft R, Suman OE, Mlcak RP and Herndon DN:
Long-term persistance of the pathophysiologic response to severe
burn injury. PLoS One. 6:e212452011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gray P, Kirby J, Smith MT, Cabot PJ,
Williams B, Doecke J and Cramond T: Pregabalin in severe burn
injury pain: A double-blind, randomised placebo-controlled trial.
Pain. 152:1279–1288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Diaz EC, Herndon DN, Lee J, Porter C,
Cotter M, Suman OE, Sidossis LS and Børsheim E: Predictors of
muscle protein synthesis after severe pediatric burns. J Trauma
Acute Care Surg. 78:816–822. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mariano F, Tedeschi L, Morselli M, Stella
M and Triolo G: Normal citratemia and metabolic tolerance of
citrate anticoagulation for hemodiafiltration in severe septic
shock burn patients. Intensive Care Med. 36:1735–1743. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miller AC, Elamin EM and Suffredini AF:
Inhaled anticoagulation regimens for the treatment of smoke
inhalation-associated acute lung injury: A systematic review. Crit
Care Med. 42:413–419. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gille J, Sablotzki A, Malcharek M, Raff T,
Mogk M and Parentin T: Regional citrate anticoagulation for
continuous renal replacement therapy in severe burns-a
retrospective analysis of a protocol-guided approach. Burns.
40:1593–1601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ono I, Ohura T, Azami K, Hoshi M and
Hasegawa T: Anticoagulation therapy for renal insufficiency after
burns. Burns Incl Therm Inj. 11:104–110. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sorg H, Hoffmann JO, Hoffmann JN and
Vollmar B: Analysis of the influence of antithrombin on
microvascular thrombosis: Anti-inflammation is crucial for
anticoagulation. Intensive Care Med Exp. 3:582015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mohebali J, Ibrahim AE, MacGillivray TE,
Goverman J and Fagan SP: Mitral valve repair via right thoracotomy
for multidrug resistant pseudomonal endocarditis in a burn patient:
Case report and review of the literature. Burns. 41:e47–e50. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pourafkari L, Ghaffari S, Khaki N, Hobika
GH, Masnadi-Shirazi K and Nader ND: Predictors of hospital
mortality and serious complications in patients admitted with
excessive warfarin anticoagulation. Thromb Res. 137:79–84. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
van den Bergh WM, Lansink-Hartgring AO,
van Duijn AL, Engström AE, Lahpor JR and Slooter AJ: Thromboembolic
stroke in patients with a HeartMate-II left ventricular assist
device-the role of anticoagulation. J Cardiothorac Surg.
10:1282015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moeinipour A, Zarifian A, Andalibi MS
Sheikh, Shamloo AS, Ahmadabadi A, Amouzeshi A and Hoseinikhah H:
The best anticoagulation therapy in multiple-trauma patients with
mechanical heart valves: Evaluation of latest guidelines and
studies. Heart Surg Forum. 18:E271–E274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maybauer MO, Maybauer DM, Fraser JF,
Westphal M, Szabó C, Cox RA, Hawkins HK, Traber LD and Traber DL:
Combined recombinant human activated protein C and ceftazidime
prevent the onset of acute respiratory distress syndrome in severe
sepsis. Shock. 37:170–176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schleich AR, Schweiger H, Becsey A and
Cruse CW: Survival after severe intrathoracic electrical injury.
Burns. 36:e61–e64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Levy JH, Sniecinski RM, Welsby IJ and Levi
M: Antithrombin: Anti-inflammatory properties and clinical
applications. Thromb Haemost. 115:712–728. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ruan Q, Zhao C, Ye Z, Ruan J, Xie Q and
Xie W: Effect and possible mechanism of monocyte-derived VEGF on
monocyte-endothelial cellular adhesion after electrical burns.
Burns. 41:825–832. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim YR and Hong SH: Association between
the polymorphisms of the vascular endothelial growth factor gene
and metabolic syndrome. Biomed Rep. 3:319–326. 2015.PubMed/NCBI
|
|
19
|
Azhar A, Singh P, Rashid Q, Naseem A, Khan
MS and Jairajpuri MA: Antiangiogenic function of antithrombin is
dependent on its conformational variation: Implication for other
serpins. Protein Pept Lett. 20:403–411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gurbel PA, Bliden KP, Turner SE, Tantry
US, Gesheff MG, Barr TP, Covic L and Kuliopulos A: Cell-penetrating
pepducin therapy targeting PAR1 in subjects with coronary artery
disease. Arterioscler Thromb Vasc Biol. 36:189–197. 2016.PubMed/NCBI
|
|
21
|
Simmons S, Lee RV, Möller T and Weinstein
JR: Thrombin induces release of proinflammatory chemokines
interleukin-8 and interferon-γ-induced protein-10 from cultured
human fetal astrocytes. Neuroreport. 24:36–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tantivejkul K, Loberg RD, Mawocha SC, Day
LL, John LS, Pienta BA, Rubin MA and Pienta KJ: PAR1-mediated
NFkappaB activation promotes survival of prostate cancer cells
through a Bcl-xL-dependent mechanism. J Cell Biochem. 96:641–652.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hashemzadeh M, Arreguin JM, Roberts T and
Movahed MR: A novel inhibitor of protease-activated receptor 1: A
review of chemical structure and mode of action. Rev Cardiovasc
Med. 16:68–73. 2015.PubMed/NCBI
|
|
24
|
Austin KM, Covic L and Kuliopulos A:
Matrix metalloproteases and PAR1 activation. Blood. 121:431–439.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Balzarotti M, Fontana F, Marras C, Boiardi
A, Croci D, Ciusani E and Salmaggi A: In vitro study of low
molecular weight heparin effect on cell growth and cell invasion in
primary cell cultures of high-grade gliomas. Oncol Res. 16:245–250.
2006.PubMed/NCBI
|
